US FDA authorises Pfizer COVID-19 jab for kids aged 5 to 11
Pfizer-BioNTech said their vaccine showed 90.7 percent efficacy against COVID-19 in a clinical trial of kids aged 5-11.Pfizer-BioNTech said their vaccine showed 90.7 percent efficacy against COVID-19 in a clinical trial of kids aged 5-11.